US$ 21.83
blue cross blue shield plans reverse course on glp-1 coverage Why is rolling back of weight loss drugs in Massachusetts GLP-1 Drugs Could Raise Employer
Description
Glucose variability based on continuous glucose monitoring assessment is associated with postoperative complications after cardiovascular surgery
Denosumab improves glycaemic parameters in postmenopausal osteoporosis patients with combined type 2 diabetes mellitus
doi: 10.1111/cup.12246

Cost and accessibility GLP-1RA is expensive, which limits its popularity in low-income countries and regions

doi: 10.1056/NEJMoa2302392